Search by Drug Name or NDC
NDC 60846-0301-15 NIZATIDINE 15 mg/mL Details
NIZATIDINE 15 mg/mL
NIZATIDINE is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is NIZATIDINE.
MedlinePlus Drug Summary
Nizatidine is used to treat and prevent the recurrence of ulcers and to treat other conditions where the stomach makes too much acid. Nizatidine also is used to treat or prevent occasional heartburn, acid indigestion, or sour stomach. It decreases the amount of acid made in the stomach. Nizatidine is available with and without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 60846-0301-15Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Nizatidine
Product Information
NDC | 60846-0301 |
---|---|
Product ID | 60846-301_3fd0903c-07b8-420b-bdd7-258259d91920 |
Associated GPIs | 49200040002050 |
GCN Sequence Number | 057867 |
GCN Sequence Number Description | nizatidine SOLUTION 150MG/10ML ORAL |
HIC3 | Z2D |
HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
GCN | 23129 |
HICL Sequence Number | 004522 |
HICL Sequence Number Description | NIZATIDINE |
Brand/Generic | Generic |
Proprietary Name | NIZATIDINE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | NIZATIDINE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 15 |
Active Ingredient Units | mg/mL |
Substance Name | NIZATIDINE |
Labeler Name | Amneal Pharmaceuticals LLC |
Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090576 |
Listing Certified Through | 2022-12-31 |
Package
NDC 60846-0301-15 (60846030115)
NDC Package Code | 60846-301-15 |
---|---|
Billing NDC | 60846030115 |
Package | 480 mL in 1 BOTTLE (60846-301-15) |
Marketing Start Date | 2016-08-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |